Ge Long Hui·2025-08-18 02:05Core Viewpoint - The pharmaceutical sector has shown significant stock price increases, with several companies experiencing notable gains in their share prices recently [1][2]. Group 1: Stock Performance - Hanyu Pharmaceutical (300199) saw a rise of 12.05%, with a total market capitalization of 25.8 billion [2]. - Wanbangde (002082) achieved a 10.01% increase, with a market cap of 4.906 billion [2]. - Tianshili (600535) increased by 7.73%, with a market value of 26 billion [2]. - Shanghai Yizhong (688091) rose by 6.94%, with a market cap of 16.9 billion [2]. - Olin Bio (688319) and Sunshine Nuohe (688621) both increased by over 5%, with market caps of 10.3 billion and 9.033 billion respectively [2]. - Other companies like Nuo Silan De (430047), Haita Bio (300683), and Nanxin Pharmaceutical (688189) also reported gains of over 4% [2]. Group 2: Year-to-Date Performance - Hanyu Pharmaceutical (300199) has shown a year-to-date increase of 126.53% [2]. - Olin Bio (688319) and Sunshine Nuohe (688621) have year-to-date increases of 139.06% and 114.56% respectively [2]. - Haita Bio (300683) and Nanxin Pharmaceutical (688189) also reported significant year-to-date increases of 143.08% and 114.53% respectively [2].